ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 67.25

Change

+0.11 (+0.16)%

Market Cap

CAD 0.26B

Volume

3.65K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-18 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

N/A

CAD 3.16B
ZWU:CA BMO Covered Call Utilities ETF

+0.06 (+0.55%)

CAD 1.90B
XIT:CA iShares S&P/TSX Capped Informa..

-0.28 (-0.42%)

CAD 0.69B
TXF:CA First Asset Tech Giants Covere..

+0.13 (+0.61%)

CAD 0.68B
HTA:CA Harvest Tech Achievers Growth ..

+0.11 (+0.58%)

CAD 0.64B
XHC:CA iShares Global Healthcare (CAD..

-0.18 (-0.26%)

CAD 0.60B
ZUT:CA BMO Equal Weight Utilities Ind..

-0.01 (-0.05%)

CAD 0.56B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.10 (+0.36%)

CAD 0.36B
CWW:CA iShares Global Water Common Cl..

+0.11 (+0.18%)

CAD 0.34B
COW:CA iShares Global Agriculture Com..

-0.05 (-0.08%)

CAD 0.28B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.32% 14% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.32% 11% F 14% F
Trailing 12 Months  
Capital Gain 6.61% 26% F 32% F
Dividend Return 0.80% 25% F 5% F
Total Return 7.41% 17% F 23% F
Trailing 5 Years  
Capital Gain 16.37% 34% F 51% F
Dividend Return 2.38% 16% F 4% F
Total Return 18.75% 17% F 36% F
Average Annual (5 Year Horizon)  
Capital Gain 4.44% 31% F 51% F
Dividend Return 4.83% 26% F 48% F
Total Return 0.38% 30% F 34% F
Risk Return Profile  
Volatility (Standard Deviation) 16.25% 63% D 52% F
Risk Adjusted Return 29.69% 26% F 47% F
Market Capitalization 0.26B 71% C- 49% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.